<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39571342</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-1983</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>14</Day></PubDate></JournalIssue><Title>Clinical nutrition (Edinburgh, Scotland)</Title><ISOAbbreviation>Clin Nutr</ISOAbbreviation></Journal><ArticleTitle>Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial.</ArticleTitle><Pagination><StartPage>344</StartPage><EndPage>358</EndPage><MedlinePgn>344-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnu.2024.11.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0261-5614(24)00420-5</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">Long-term effects of coronavirus disease 2019 (long COVID) develop in a substantial number of people following an acute COVID-19 episode. Red beetroot juice may have positive effects on multiple pathways involved in long COVID. The aim of this pilot study was to explore the impact of beetroot juice supplementation on physical function, gut microbiota, and systemic inflammation in adults with long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A single-center, double-blind, placebo-controlled randomized trial was conducted to test the effects of 14 days of beetroot juice supplementation, rich in nitrates and betalains, on functional and biological outcomes in adults aged between 20 and 60 years with long COVID. Participants were randomized 1:1 to receive either daily oral supplementation with 200&#xa0;mL beetroot juice (&#x223c;600&#xa0;mg nitrate) or placebo (&#x223c;60&#xa0;mg nitrate) for 14 days. The primary endpoint was the change from baseline to day 14 in a fatigue resistance test. Secondary outcomes included the distance walked on the 6-min walk test, handgrip strength, and flow-mediated dilation. Secondary endpoints also included changes from baseline in circulating inflammatory mediators and metagenomic and fecal water metabolomic profiles. Partial least squares discriminant analysis (PLS-DA) models were built to evaluate the differences in biological variables associated with the interventions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-one participants were randomized in the study. Twenty-five of them (median (interquartile range) age 40 (10), 14 [56&#xa0;%] women), received either beetroot juice (15) or placebo (10) and completed the study. At 14 days, fatigue resistance significantly improved from baseline (mean difference [standard error]:&#xa0;+21.8 [3.7] s; p&#xa0;&lt;&#xa0;0.001) with no significant differences between intervention groups. A significant increase from baseline in the distance walked on the 6-min walk test was observed (mean difference [standard error]:&#xa0;+30.0 [9.4] m; p&#xa0;=&#xa0;0.03), which was not different between groups. Flow-mediated dilation did not differ between participants who received beetroot juice and those on placebo. PLS-DA models allowed correct classification of participants with 92.2&#xa0;&#xb1;&#xa0;4.4&#xa0;% accuracy. Those who ingested red beetroot juice had a greater abundance of bacteria with well-known beneficial effects, including Akkermansia, Oscillospira, Prevotella, Roseburia, Ruminococcaceae, and Turicibacter, compared with placebo. Participants allocated to beetroot juice supplementation were also characterized by significantly higher levels of fecal nicotinate, trimethylamine, and markers of beetroot juice intake (e.g., 5,6-dihydroxyindole). Finally, higher levels of interferon gamma and macrophage inflammatory protein-1&#x3b2; were found in participants who consumed beetroot juice.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Beetroot juice supplementation for two weeks did not to induce significant improvements in functional outcomes in adults with long COVID compared with placebo. Beneficial effects were observed in both gut microbiota composition (i.e., increase in probiotic species) and inflammatory mediators.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Trial was registered under ClinicalTrials.gov. Identifier no. NCT06535165.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Calvani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Universit&#xe0; Cattolica del Sacro Cuore, L.go F. Vito 1, 00618 Rome, Italy; Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: riccardo.calvani@unicatt.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giampaoli</LastName><ForeName>Ottavia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Environmental Biology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy; NMR-Based Metabolomics Laboratory (NMLab), Sapienza University of Rome, Rome, Italy. Electronic address: ottavia.giampaoli@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>NMR-Based Metabolomics Laboratory (NMLab), Sapienza University of Rome, Rome, Italy; Department of Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy. Electronic address: federico.marini@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Chierico</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Microbiome, Bambino Ges&#xf9; Children's Hospital IRCCS, Piazza di Sant'Onofrio 4, 00165 Rome, Italy. Electronic address: federica.delchierico@opbg.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rosa</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy. Electronic address: michele.derosa@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conta</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Environmental Biology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy. Electronic address: giorgia.conta@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sciubba</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Environmental Biology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy; NMR-Based Metabolomics Laboratory (NMLab), Sapienza University of Rome, Rome, Italy. Electronic address: fabio.sciubba@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosato</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: matteo.tosato@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picca</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy; Department of Medicine and Surgery, LUM University, SS100 km 18, 70010 Casamassima, Italy. Electronic address: picca@lum.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciciarello</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: francesca.ciciarello@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galluzzo</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: vincenzo.galluzzo@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gervasoni</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: jacopo.gervasoni@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Mario</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Immunology Core Facility, GSTEP, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: clara.dimario@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: luca.santoro@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolusso</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Immunology Core Facility, GSTEP, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: barbara.tolusso@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spagnoli</LastName><ForeName>Mariangela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, INAIL, Via Fontana Candida 1, 00078 Monte Porzio Catone, Italy. Electronic address: m.spagnoli@inail.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomassini</LastName><ForeName>Alberta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>R&amp;D, Aureli Mario S.S. Agricola, Via Mario Aureli 7, 67050 Ortucchio, L'Aquila, Italy. Electronic address: tomassinialberta@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aureli</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>R&amp;D, Aureli Mario S.S. Agricola, Via Mario Aureli 7, 67050 Ortucchio, L'Aquila, Italy. Electronic address: produzione@aurelimario.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toto</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Microbiome, Bambino Ges&#xf9; Children's Hospital IRCCS, Piazza di Sant'Onofrio 4, 00165 Rome, Italy. Electronic address: Francesca.toto@opbg.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pane</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Microbiomics, Bambino Ges&#xf9; Children's Hospital IRCCS, Piazza di Sant'Onofrio 4, 00165 Rome, Italy. Electronic address: stefania.pane@opbg.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putignani</LastName><ForeName>Lorenza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Microbiomics and Unit of Microbiome, Bambino Ges&#xf9; Children's Hospital IRCCS, Piazza di Sant'Onofrio 4, 00165 Rome, Italy. Electronic address: lorenza.putignani@opbg.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miccheli</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NMR-Based Metabolomics Laboratory (NMLab), Sapienza University of Rome, Rome, Italy. Electronic address: alfredo.miccheli@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzetti</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Universit&#xe0; Cattolica del Sacro Cuore, L.go F. Vito 1, 00618 Rome, Italy; Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: emanuele.marzetti@unicatt.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Orthopedics and Rheumatology, Universit&#xe0; Cattolica del Sacro Cuore, L.go F. Vito 1, 00618 Rome, Italy; Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy. Electronic address: francesco.landi@unicatt.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Gemelli against COVID-19 Post-Acute Care Team</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06535165</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr</MedlineTA><NlmUniqueID>8309603</NlmUniqueID><ISSNLinking>0261-5614</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Betalains</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Gut microbiota</Keyword><Keyword MajorTopicYN="N">Metabolomics</Keyword><Keyword MajorTopicYN="N">Nitrate</Keyword><Keyword MajorTopicYN="N">Red beetroot juice</Keyword></KeywordList><CoiStatement>Conflict of interest A.T. and W.A. are employees of Aureli Mario S.S. Agricola, which donated both beetroot juice and placebo for the study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>22</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>22</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>21</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39571342</ArticleId><ArticleId IdType="doi">10.1016/j.clnu.2024.11.023</ArticleId><ArticleId IdType="pii">S0261-5614(24)00420-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>